M T Kinirons, S H Jackson, L Kalra, R T Trevit, C G Swift
Index: Br. J. Clin. Pharmacol. 36(4) , 376-9, (1993)
Full Text: HTML
The psychomotor and cardiovascular effects of minaprine 100 mg, a novel antidepressant, were compared with amitriptyline 25 mg, as a positive control, and placebo in a single dose randomised double-blind crossover trial using an automated psychomotor test battery (APT), postural sway (PS), blood pressure (BP) and pulse in nine young and nine elderly healthy subjects. Analysis of variance, taking into account baseline values, showed that continuous attention test (CAT), critical flicker fusion threshold (CFFT), decision making test (DMT) and paired word association (PWA) were significantly impaired with amitriptyline compared with minaprine and placebo. Minaprine did not differ from placebo. Amitriptyline significantly lowered supine systolic blood pressure (BP) and all treatments produced significant decreases in heart rate in young and elderly. No age effect on psychomotor performance was seen. Minaprine compared favourably with amitriptyline using the APT with the doses used. The APT is useful in the evaluation of new drugs on psychomotor performance.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Minaprine
CAS:25905-77-5 |
C17H22N4O |
Multicentric double-blind study comparing efficacy and safet...
1995-01-01 [Neuropsychobiology 31(2) , 68-75, (1995)] |
Cholinomimetic activity of minaprine is related to the ameli...
1992-07-01 [Physiol. Behav. 52(1) , 141-7, (1992)] |
Minaprine facilitates acquisition and retrieval of an active...
1993-06-01 [Pharmacol. Biochem. Behav. 45(2) , 481-5, (1993)] |
Effects of subchronic minaprine on dopamine release in the v...
1994-01-17 [Neurosci. Lett. 166(1) , 69-72, (1994)] |
Involvement of protein kinase C activation in regulation of ...
1994-01-01 [Neurochem. Int. 24(1) , 37-41, (1994)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved